Carina Biotech are an Australian biotech company researching and developing chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers, including paediatric and rare cancers.
Carina currently have three core technologies that they are marketing including:
Some of these cookies are essential for the website to function correctly, while others may collect your personal information. In some cases, the personal information collected by our cookies may be shared with third party service providers.
For details about the categories of cookies that we use, and to set your cookie preferences, please select ‘More information’ before you continue. For an overview see our Privacy Statement, or review our Privacy Policy in full.